Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
Bullboard Posts
User Avatar Image
(2)
•••
Comment by labumbaon May 02, 2006 11:41pm
424 Views
Post# 10777043

RE: T-mins 60 days...

RE: T-mins 60 days...nowayout, to say the least I have been " gunhoo " about ISA247. It should have been $10 by now..there isn't a glitch of the science ...I think the market is brutal to BioTech...the street is only interested in " oil "..for quick bucks ! don't get me wrong...I have increased my positon since the new deal with Roche. No doubt ISA247 is the winner of head-to-head trial and I don't want getting into a debate of " why "....so what if they are the winner...we have to wait for one year and meanwhile this stock is now sitting at 2 bucks...how long they can sustain this price is a good question as they are not supporting the stock unless we have some good news like update on renal2B. This summer can be high and dry....getting an US listing...most unlikely...they first have to get a strategic parntner for the US psoriasis trial ,IMO.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities